首页> 外文期刊>Molecular medicine reports >Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison
【24h】

Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison

机译:使用基因集富集分析,荟萃分析和跨物种比较,鉴定肝细胞癌关键基因并验证候选基因cdc25a

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of the present study was to determine key pathways and genes involved in the pathogenesis of hepatocellular carcinoma (HCC) through bioinformatic analyses of HCC microarray data based on cross-species comparison. Microarray data of gene expression in HCC in different species were analyzed using gene set enrichment analysis (GSEA) and meta-analysis. Reverse transcription-quantitative polymerase chain reaction and western blotting were performed to determine the mRNA and protein expression levels of cdc25a, one of the identified candidate genes, in human, rat and tree shrew samples. The cell cycle pathway had the largest overlap between the GSEA and meta-analysis. Meta-analyses showed that 25 genes, including cdc25a, in the cell cycle pathway were differentially expressed. Cdc25a mRNA levels in HCC tissues were higher than those in normal liver tissues in humans, rats and tree shrews, and the expression level of cdc25a in HCC tissues was higher than in corresponding paraneoplastic tissues in humans and rats. In human HCC tissues, the cdc25a mRNA level was significantly correlated with clinical stage, portal vein tumor thrombosis and extrahepatic metastasis. Western blotting showed that, cdc25a protein levels were significantly upregulated in HCC tissues in humans, rats and tree shrews. In conclusion, GSEA and meta-analysis can be combined to identify key molecules and pathways involved in HCC. This study demonstrated that the cell cycle pathway and the cdc25a gene may be crucial in the pathogenesis and progression of HCC.
机译:本研究的目的是通过基于跨物种比较的HCC芯片数据的生物信息学分析,确定肝细胞癌(HCC)发病机理中涉及的关键途径和基因。使用基因组富集分析(GSEA)和荟萃分析分析了不同物种中HCC基因表达的微阵列数据。进行了逆转录定量聚合酶链反应和蛋白质印迹,以确定了人类,大鼠和树木sh样品中cdc25a的mRNA和蛋白质表达水平,cdc25a是已鉴定的候选基因之一。细胞周期途径在GSEA和荟萃分析之间有最大的重叠。荟萃分析显示,细胞周期途径中的25个基因(包括cdc25a)被差异表达。人,大鼠和树sh的肝癌组织中Cdc25a mRNA的表达均高于正常肝组织,人和大鼠的肝癌组织中cdc25a的表达水平也高于相应的副肿瘤组织。在人类肝癌组织中,cdc25a mRNA水平与临床分期,门静脉肿瘤血栓形成和肝外转移密切相关。蛋白质印迹表明,人,大鼠和树tree的HCC组织中的cdc25a蛋白水平显着上调。总之,可以将GSEA和荟萃分析相结合,以鉴定参与HCC的关键分子和途径。这项研究表明,细胞周期途径和cdc25a基因可能在肝癌的发生和发展中至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号